Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
CALL
Enbridge
ENB
$121B
| $47.4M | 0.03% |
+940,000
| New | +$37.1M |
|
|
GTM
652
ZoomInfo Technologies
GTM
$967M
| $47.4M | 0.03% |
775,018
+547,950
| +241% | +$32.8M |
|
653
Northern Trust
NTRS
$22.2B
| $47.1M | 0.03% |
437,271
+74,767
| +21% | +$8.49M |
|
654
Neurocrine Biosciences
NBIX
$18.4B
| $47.1M | 0.03% |
491,244
+369,733
| +304% | +$34.9M |
|
655
Snowflake
SNOW
$93.7B
| $47.1M | 0.03% |
155,747
+95,086
| +157% | +$27M |
|
|
XLRN
656
DELISTED
Acceleron Pharma
XLRN
| $47.1M | 0.03% |
273,520
+261,193
| +2,119% | +$34.2M |
|
|
IPOF
657
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
| $47M | 0.03% |
4,632,932
+353,446
| +8% | +$3.55M |
|
658
Gartner
IT
$10.4B
| $47M | 0.03% |
154,739
-67,861
| -30% | -$19.7M |
|
659
Exelon
EXC
$48.4B
| $47M | 0.03% |
1,362,883
+622,854
| +84% | +$21.3M |
|
660
CALL
Las Vegas Sands
LVS
$32B
| $46.9M | 0.03% |
1,282,200
+752,200
| +142% | +$32.3M |
|
661
SS&C Technologies
SSNC
$18.8B
| $46.9M | 0.03% |
675,589
-247,646
| -27% | -$18.4M |
|
|
PACW
662
DELISTED
PacWest Bancorp
PACW
| $46.8M | 0.03% |
1,033,677
+596,219
| +136% | +$24.7M |
|
663
Performance Food Group
PFGC
$18.1B
| $46.8M | 0.03% |
1,008,144
-307,671
| -23% | -$14.2M |
|
664
Align Technology
ALGN
$12.6B
| $46.8M | 0.03% |
70,275
-171,226
| -71% | -$116M |
|
665
CALL
Thermo Fisher Scientific
TMO
$214B
| $46.7M | 0.03% |
81,700
+60,200
| +280% | +$33M |
|
|
MGP
666
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $46.7M | 0.03% |
1,218,468
-492,816
| -29% | -$19.3M |
|
667
Gaming and Leisure Properties
GLPI
$13B
| $46.6M | 0.03% |
1,006,788
+224,441
| +29% | +$10.7M |
|
668
Datadog
DDOG
$89.3B
| $46.6M | 0.03% |
329,881
+74,148
| +29% | +$9.36M |
|
669
Churchill Downs
CHDN
$6.22B
| $46.6M | 0.03% |
387,972
-448,712
| -54% | -$45.6M |
|
|
VMW
670
PUT
DELISTED
VMware, Inc
VMW
| $46.3M | 0.03% |
311,600
-49,800
| -14% | -$7.55M |
|
671
Bio-Techne
TECH
$11.2B
| $46.3M | 0.03% |
382,360
+346,188
| +957% | +$42.1M |
|
672
Sociedad Química y Minera de Chile
SQM
$19.1B
| $46.3M | 0.03% |
862,036
+419,278
| +95% | +$21.4M |
|
673
CALL
Sun Life Financial
SLF
$46.6B
| $46.3M | 0.03% |
+710,000
| New | +$36.5M |
|
674
Upstart Holdings
UPST
$2.66B
| $46M | 0.03% |
145,524
+116,996
| +410% | +$23.1M |
|
675
Air Products & Chemicals
APD
$65.2B
| $46M | 0.03% |
179,581
+38,193
| +27% | +$10.6M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.